0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Real-time PCR Instruments and Reagents Market Research Report 2026
Published Date: 2026-04-22
|
Report Code: QYRE-Auto-21B13019
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Real time PCR Instrumentsand Reagents Market Research Report 2023
BUY CHAPTERS

Global Real-time PCR Instruments and Reagents Market Research Report 2026

Code: QYRE-Auto-21B13019
Report
2026-04-22
Pages:159
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Real-time PCR Instruments and Reagents Market Size

The global Real-time PCR Instruments and Reagents market was valued at US$ 7974 million in 2025 and is anticipated to reach US$ 13130 million by 2032, at a CAGR of 7.5% from 2026 to 2032.

Real-time PCR Instruments and Reagents Market

Real-time PCR Instruments and Reagents Market

In conventional PCR, the amplified DNA product, or amplicon, is detected in an end-point analysis. In real-time PCR, the accumulation of amplification product is measured as the reaction progresses, in real time, with product quantification after each cycle. The main advantage of real-time PCR over PCR is that real-time PCR allows you to determine the initial number of copies of template DNA (the amplification target sequence) with accuracy and high sensitivity over a wide dynamic range. Real-time PCR results can either be qualitative (the presence or absence of a sequence) or quantitative (copy number). Quantitative real-time PCR is thus also known as qPCR analysis. In contrast, PCR is at best semiquantitative. Additionally, real-time qPCR data can be evaluated without gelelectrophoresis, resulting in reduced bench time and increased throughput. Finally, because real-time qPCR reactions are run and data are evaluated in a unified, closed-tube qPCR system, opportunities for contamination are reduced and the need for postamplification manipulation is eliminated in qPCR analysis.
In Middle East, key players of real-time PCR instruments and reagents include Bioeksen R&D Technologies, Sansure Biotech, Thermo Fisher Scientific, etc. The top three players hold a share about 34%. Egypt is the largest market in Middle East, has around 27% share, followed by Turkey and Saudi Arabia, with about 25% and 18% share, respectively.
This report delivers a comprehensive overview of the global Real-time PCR Instruments and Reagents market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Real-time PCR Instruments and Reagents. The Real-time PCR Instruments and Reagents market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Real-time PCR Instruments and Reagents market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Real-time PCR Instruments and Reagents manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Real-time PCR Instruments and Reagents Market Report

Report Metric Details
Report Name Real-time PCR Instruments and Reagents Market
Accounted market size in 2025 US$ 7974 million
Forecasted market size in 2032 US$ 13130 million
CAGR 7.5%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Reagent
  • Instrument
Segment by Application
  • Infectious Disease
  • Prenatal and Postnatal Care
  • Cancer Screening and Treatment
  • Organ Transplant
  • Individual Identification
  • Agriculture
  • Customs Quarantine
  • Food Safety
  • Forensic
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific, Roche, DaAn Gene, Sansure Biotech, QIAGEN, Bio-Rad, Biosynex, Cepheid, Hangzhou Bloer Technology, Liferiver Bio-Tech, Xi'an Tianlong Science and Technology, Bioperfectus Technologies, BGI Group, Agilent Technologies, Hybribio, Shanghai Biogerm Medical, Shanghai Hongshi Medical Technology, Suzhou Molarray, Merck, Analytik Jena, Takara, Meridian Life Science, Promega Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Real-time PCR Instruments and Reagents companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Real-time PCR Instruments and Reagents Market growing?

Ans: The Real-time PCR Instruments and Reagents Market witnessing a CAGR of 7.5% during the forecast period 2026-2032.

What is the Real-time PCR Instruments and Reagents Market size in 2032?

Ans: The Real-time PCR Instruments and Reagents Market size in 2032 will be US$ 13130 million.

What is the market share of major companies in Real-time PCR Instruments and Reagents Market?

Ans: The top three players hold a share about 34%.

Who are the main players in the Real-time PCR Instruments and Reagents Market report?

Ans: The main players in the Real-time PCR Instruments and Reagents Market are Thermo Fisher Scientific, Roche, DaAn Gene, Sansure Biotech, QIAGEN, Bio-Rad, Biosynex, Cepheid, Hangzhou Bloer Technology, Liferiver Bio-Tech, Xi'an Tianlong Science and Technology, Bioperfectus Technologies, BGI Group, Agilent Technologies, Hybribio, Shanghai Biogerm Medical, Shanghai Hongshi Medical Technology, Suzhou Molarray, Merck, Analytik Jena, Takara, Meridian Life Science, Promega Corporation

What are the Application segmentation covered in the Real-time PCR Instruments and Reagents Market report?

Ans: The Applications covered in the Real-time PCR Instruments and Reagents Market report are Infectious Disease, Prenatal and Postnatal Care, Cancer Screening and Treatment, Organ Transplant, Individual Identification, Agriculture, Customs Quarantine, Food Safety, Forensic, Other

What are the Type segmentation covered in the Real-time PCR Instruments and Reagents Market report?

Ans: The Types covered in the Real-time PCR Instruments and Reagents Market report are Reagent, Instrument

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Real-time PCR Instruments and Reagents Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Reagent
1.2.3 Instrument
1.3 Market by Application
1.3.1 Global Real-time PCR Instruments and Reagents Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Infectious Disease
1.3.3 Prenatal and Postnatal Care
1.3.4 Cancer Screening and Treatment
1.3.5 Organ Transplant
1.3.6 Individual Identification
1.3.7 Agriculture
1.3.8 Customs Quarantine
1.3.9 Food Safety
1.3.10 Forensic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Real-time PCR Instruments and Reagents Market Perspective (2021–2032)
2.2 Global Real-time PCR Instruments and Reagents Growth Trends by Region
2.2.1 Global Real-time PCR Instruments and Reagents Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Real-time PCR Instruments and Reagents Historic Market Size by Region (2021–2026)
2.2.3 Real-time PCR Instruments and Reagents Forecasted Market Size by Region (2027–2032)
2.3 Real-time PCR Instruments and Reagents Market Dynamics
2.3.1 Real-time PCR Instruments and Reagents Industry Trends
2.3.2 Real-time PCR Instruments and Reagents Market Drivers
2.3.3 Real-time PCR Instruments and Reagents Market Challenges
2.3.4 Real-time PCR Instruments and Reagents Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Real-time PCR Instruments and Reagents Players by Revenue
3.1.1 Global Top Real-time PCR Instruments and Reagents Players by Revenue (2021–2026)
3.1.2 Global Real-time PCR Instruments and Reagents Revenue Market Share by Players (2021–2026)
3.2 Global Top Real-time PCR Instruments and Reagents Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Real-time PCR Instruments and Reagents Revenue
3.4 Global Real-time PCR Instruments and Reagents Market Concentration Ratio
3.4.1 Global Real-time PCR Instruments and Reagents Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Real-time PCR Instruments and Reagents Revenue in 2025
3.5 Global Key Players of Real-time PCR Instruments and Reagents Head Offices and Areas Served
3.6 Global Key Players of Real-time PCR Instruments and Reagents, Products and Applications
3.7 Global Key Players of Real-time PCR Instruments and Reagents, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Real-time PCR Instruments and Reagents Breakdown Data by Type
4.1 Global Real-time PCR Instruments and Reagents Historic Market Size by Type (2021–2026)
4.2 Global Real-time PCR Instruments and Reagents Forecasted Market Size by Type (2027–2032)
5 Real-time PCR Instruments and Reagents Breakdown Data by Application
5.1 Global Real-time PCR Instruments and Reagents Historic Market Size by Application (2021–2026)
5.2 Global Real-time PCR Instruments and Reagents Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Real-time PCR Instruments and Reagents Market Size (2021–2032)
6.2 North America Real-time PCR Instruments and Reagents Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Real-time PCR Instruments and Reagents Market Size by Country (2021–2026)
6.4 North America Real-time PCR Instruments and Reagents Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Real-time PCR Instruments and Reagents Market Size (2021–2032)
7.2 Europe Real-time PCR Instruments and Reagents Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Real-time PCR Instruments and Reagents Market Size by Country (2021–2026)
7.4 Europe Real-time PCR Instruments and Reagents Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Real-time PCR Instruments and Reagents Market Size (2021–2032)
8.2 Asia-Pacific Real-time PCR Instruments and Reagents Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Real-time PCR Instruments and Reagents Market Size by Region (2021–2026)
8.4 Asia-Pacific Real-time PCR Instruments and Reagents Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Real-time PCR Instruments and Reagents Market Size (2021–2032)
9.2 Latin America Real-time PCR Instruments and Reagents Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Real-time PCR Instruments and Reagents Market Size by Country (2021–2026)
9.4 Latin America Real-time PCR Instruments and Reagents Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Real-time PCR Instruments and Reagents Market Size (2021–2032)
10.2 Middle East & Africa Real-time PCR Instruments and Reagents Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Real-time PCR Instruments and Reagents Market Size by Country (2021–2026)
10.4 Middle East & Africa Real-time PCR Instruments and Reagents Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Real-time PCR Instruments and Reagents Introduction
11.1.4 Thermo Fisher Scientific Revenue in Real-time PCR Instruments and Reagents Business (2021–2026)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Real-time PCR Instruments and Reagents Introduction
11.2.4 Roche Revenue in Real-time PCR Instruments and Reagents Business (2021–2026)
11.2.5 Roche Recent Development
11.3 DaAn Gene
11.3.1 DaAn Gene Company Details
11.3.2 DaAn Gene Business Overview
11.3.3 DaAn Gene Real-time PCR Instruments and Reagents Introduction
11.3.4 DaAn Gene Revenue in Real-time PCR Instruments and Reagents Business (2021–2026)
11.3.5 DaAn Gene Recent Development
11.4 Sansure Biotech
11.4.1 Sansure Biotech Company Details
11.4.2 Sansure Biotech Business Overview
11.4.3 Sansure Biotech Real-time PCR Instruments and Reagents Introduction
11.4.4 Sansure Biotech Revenue in Real-time PCR Instruments and Reagents Business (2021–2026)
11.4.5 Sansure Biotech Recent Development
11.5 QIAGEN
11.5.1 QIAGEN Company Details
11.5.2 QIAGEN Business Overview
11.5.3 QIAGEN Real-time PCR Instruments and Reagents Introduction
11.5.4 QIAGEN Revenue in Real-time PCR Instruments and Reagents Business (2021–2026)
11.5.5 QIAGEN Recent Development
11.6 Bio-Rad
11.6.1 Bio-Rad Company Details
11.6.2 Bio-Rad Business Overview
11.6.3 Bio-Rad Real-time PCR Instruments and Reagents Introduction
11.6.4 Bio-Rad Revenue in Real-time PCR Instruments and Reagents Business (2021–2026)
11.6.5 Bio-Rad Recent Development
11.7 Biosynex
11.7.1 Biosynex Company Details
11.7.2 Biosynex Business Overview
11.7.3 Biosynex Real-time PCR Instruments and Reagents Introduction
11.7.4 Biosynex Revenue in Real-time PCR Instruments and Reagents Business (2021–2026)
11.7.5 Biosynex Recent Development
11.8 Cepheid
11.8.1 Cepheid Company Details
11.8.2 Cepheid Business Overview
11.8.3 Cepheid Real-time PCR Instruments and Reagents Introduction
11.8.4 Cepheid Revenue in Real-time PCR Instruments and Reagents Business (2021–2026)
11.8.5 Cepheid Recent Development
11.9 Hangzhou Bloer Technology
11.9.1 Hangzhou Bloer Technology Company Details
11.9.2 Hangzhou Bloer Technology Business Overview
11.9.3 Hangzhou Bloer Technology Real-time PCR Instruments and Reagents Introduction
11.9.4 Hangzhou Bloer Technology Revenue in Real-time PCR Instruments and Reagents Business (2021–2026)
11.9.5 Hangzhou Bloer Technology Recent Development
11.10 Liferiver Bio-Tech
11.10.1 Liferiver Bio-Tech Company Details
11.10.2 Liferiver Bio-Tech Business Overview
11.10.3 Liferiver Bio-Tech Real-time PCR Instruments and Reagents Introduction
11.10.4 Liferiver Bio-Tech Revenue in Real-time PCR Instruments and Reagents Business (2021–2026)
11.10.5 Liferiver Bio-Tech Recent Development
11.11 Xi'an Tianlong Science and Technology
11.11.1 Xi'an Tianlong Science and Technology Company Details
11.11.2 Xi'an Tianlong Science and Technology Business Overview
11.11.3 Xi'an Tianlong Science and Technology Real-time PCR Instruments and Reagents Introduction
11.11.4 Xi'an Tianlong Science and Technology Revenue in Real-time PCR Instruments and Reagents Business (2021–2026)
11.11.5 Xi'an Tianlong Science and Technology Recent Development
11.12 Bioperfectus Technologies
11.12.1 Bioperfectus Technologies Company Details
11.12.2 Bioperfectus Technologies Business Overview
11.12.3 Bioperfectus Technologies Real-time PCR Instruments and Reagents Introduction
11.12.4 Bioperfectus Technologies Revenue in Real-time PCR Instruments and Reagents Business (2021–2026)
11.12.5 Bioperfectus Technologies Recent Development
11.13 BGI Group
11.13.1 BGI Group Company Details
11.13.2 BGI Group Business Overview
11.13.3 BGI Group Real-time PCR Instruments and Reagents Introduction
11.13.4 BGI Group Revenue in Real-time PCR Instruments and Reagents Business (2021–2026)
11.13.5 BGI Group Recent Development
11.14 Agilent Technologies
11.14.1 Agilent Technologies Company Details
11.14.2 Agilent Technologies Business Overview
11.14.3 Agilent Technologies Real-time PCR Instruments and Reagents Introduction
11.14.4 Agilent Technologies Revenue in Real-time PCR Instruments and Reagents Business (2021–2026)
11.14.5 Agilent Technologies Recent Development
11.15 Hybribio
11.15.1 Hybribio Company Details
11.15.2 Hybribio Business Overview
11.15.3 Hybribio Real-time PCR Instruments and Reagents Introduction
11.15.4 Hybribio Revenue in Real-time PCR Instruments and Reagents Business (2021–2026)
11.15.5 Hybribio Recent Development
11.16 Shanghai Biogerm Medical
11.16.1 Shanghai Biogerm Medical Company Details
11.16.2 Shanghai Biogerm Medical Business Overview
11.16.3 Shanghai Biogerm Medical Real-time PCR Instruments and Reagents Introduction
11.16.4 Shanghai Biogerm Medical Revenue in Real-time PCR Instruments and Reagents Business (2021–2026)
11.16.5 Shanghai Biogerm Medical Recent Development
11.17 Shanghai Hongshi Medical Technology
11.17.1 Shanghai Hongshi Medical Technology Company Details
11.17.2 Shanghai Hongshi Medical Technology Business Overview
11.17.3 Shanghai Hongshi Medical Technology Real-time PCR Instruments and Reagents Introduction
11.17.4 Shanghai Hongshi Medical Technology Revenue in Real-time PCR Instruments and Reagents Business (2021–2026)
11.17.5 Shanghai Hongshi Medical Technology Recent Development
11.18 Suzhou Molarray
11.18.1 Suzhou Molarray Company Details
11.18.2 Suzhou Molarray Business Overview
11.18.3 Suzhou Molarray Real-time PCR Instruments and Reagents Introduction
11.18.4 Suzhou Molarray Revenue in Real-time PCR Instruments and Reagents Business (2021–2026)
11.18.5 Suzhou Molarray Recent Development
11.19 Merck
11.19.1 Merck Company Details
11.19.2 Merck Business Overview
11.19.3 Merck Real-time PCR Instruments and Reagents Introduction
11.19.4 Merck Revenue in Real-time PCR Instruments and Reagents Business (2021–2026)
11.19.5 Merck Recent Development
11.20 Analytik Jena
11.20.1 Analytik Jena Company Details
11.20.2 Analytik Jena Business Overview
11.20.3 Analytik Jena Real-time PCR Instruments and Reagents Introduction
11.20.4 Analytik Jena Revenue in Real-time PCR Instruments and Reagents Business (2021–2026)
11.20.5 Analytik Jena Recent Development
11.21 Takara
11.21.1 Takara Company Details
11.21.2 Takara Business Overview
11.21.3 Takara Real-time PCR Instruments and Reagents Introduction
11.21.4 Takara Revenue in Real-time PCR Instruments and Reagents Business (2021–2026)
11.21.5 Takara Recent Development
11.22 Meridian Life Science
11.22.1 Meridian Life Science Company Details
11.22.2 Meridian Life Science Business Overview
11.22.3 Meridian Life Science Real-time PCR Instruments and Reagents Introduction
11.22.4 Meridian Life Science Revenue in Real-time PCR Instruments and Reagents Business (2021–2026)
11.22.5 Meridian Life Science Recent Development
11.23 Promega Corporation
11.23.1 Promega Corporation Company Details
11.23.2 Promega Corporation Business Overview
11.23.3 Promega Corporation Real-time PCR Instruments and Reagents Introduction
11.23.4 Promega Corporation Revenue in Real-time PCR Instruments and Reagents Business (2021–2026)
11.23.5 Promega Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Real-time PCR Instruments and Reagents Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Reagent
 Table 3. Key Players of Instrument
 Table 4. Global Real-time PCR Instruments and Reagents Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global Real-time PCR Instruments and Reagents Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Real-time PCR Instruments and Reagents Market Size by Region (US$ Million), 2021–2026
 Table 7. Global Real-time PCR Instruments and Reagents Market Share by Region (2021–2026)
 Table 8. Global Real-time PCR Instruments and Reagents Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global Real-time PCR Instruments and Reagents Market Share by Region (2027–2032)
 Table 10. Real-time PCR Instruments and Reagents Market Trends
 Table 11. Real-time PCR Instruments and Reagents Market Drivers
 Table 12. Real-time PCR Instruments and Reagents Market Challenges
 Table 13. Real-time PCR Instruments and Reagents Market Restraints
 Table 14. Global Real-time PCR Instruments and Reagents Revenue by Players (US$ Million), 2021–2026
 Table 15. Global Real-time PCR Instruments and Reagents Market Share by Players (2021–2026)
 Table 16. Global Top Real-time PCR Instruments and Reagents Players by Tier (Tier 1, Tier 2, and Tier 3), based on Real-time PCR Instruments and Reagents Revenue, 2025
 Table 17. Ranking of Global Top Real-time PCR Instruments and Reagents Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by Real-time PCR Instruments and Reagents Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of Real-time PCR Instruments and Reagents, Headquarters and Area Served
 Table 20. Global Key Players of Real-time PCR Instruments and Reagents, Products and Applications
 Table 21. Global Key Players of Real-time PCR Instruments and Reagents, Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global Real-time PCR Instruments and Reagents Market Size by Type (US$ Million), 2021–2026
 Table 24. Global Real-time PCR Instruments and Reagents Revenue Market Share by Type (2021–2026)
 Table 25. Global Real-time PCR Instruments and Reagents Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global Real-time PCR Instruments and Reagents Revenue Market Share by Type (2027–2032)
 Table 27. Global Real-time PCR Instruments and Reagents Market Size by Application (US$ Million), 2021–2026
 Table 28. Global Real-time PCR Instruments and Reagents Revenue Market Share by Application (2021–2026)
 Table 29. Global Real-time PCR Instruments and Reagents Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 30. Global Real-time PCR Instruments and Reagents Revenue Market Share by Application (2027–2032)
 Table 31. North America Real-time PCR Instruments and Reagents Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America Real-time PCR Instruments and Reagents Market Size by Country (US$ Million), 2021–2026
 Table 33. North America Real-time PCR Instruments and Reagents Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe Real-time PCR Instruments and Reagents Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe Real-time PCR Instruments and Reagents Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe Real-time PCR Instruments and Reagents Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific Real-time PCR Instruments and Reagents Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific Real-time PCR Instruments and Reagents Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific Real-time PCR Instruments and Reagents Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America Real-time PCR Instruments and Reagents Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America Real-time PCR Instruments and Reagents Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America Real-time PCR Instruments and Reagents Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa Real-time PCR Instruments and Reagents Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa Real-time PCR Instruments and Reagents Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa Real-time PCR Instruments and Reagents Market Size by Country (US$ Million), 2027–2032
 Table 46. Thermo Fisher Scientific Company Details
 Table 47. Thermo Fisher Scientific Business Overview
 Table 48. Thermo Fisher Scientific Real-time PCR Instruments and Reagents Product
 Table 49. Thermo Fisher Scientific Revenue in Real-time PCR Instruments and Reagents Business (US$ Million), 2021–2026
 Table 50. Thermo Fisher Scientific Recent Development
 Table 51. Roche Company Details
 Table 52. Roche Business Overview
 Table 53. Roche Real-time PCR Instruments and Reagents Product
 Table 54. Roche Revenue in Real-time PCR Instruments and Reagents Business (US$ Million), 2021–2026
 Table 55. Roche Recent Development
 Table 56. DaAn Gene Company Details
 Table 57. DaAn Gene Business Overview
 Table 58. DaAn Gene Real-time PCR Instruments and Reagents Product
 Table 59. DaAn Gene Revenue in Real-time PCR Instruments and Reagents Business (US$ Million), 2021–2026
 Table 60. DaAn Gene Recent Development
 Table 61. Sansure Biotech Company Details
 Table 62. Sansure Biotech Business Overview
 Table 63. Sansure Biotech Real-time PCR Instruments and Reagents Product
 Table 64. Sansure Biotech Revenue in Real-time PCR Instruments and Reagents Business (US$ Million), 2021–2026
 Table 65. Sansure Biotech Recent Development
 Table 66. QIAGEN Company Details
 Table 67. QIAGEN Business Overview
 Table 68. QIAGEN Real-time PCR Instruments and Reagents Product
 Table 69. QIAGEN Revenue in Real-time PCR Instruments and Reagents Business (US$ Million), 2021–2026
 Table 70. QIAGEN Recent Development
 Table 71. Bio-Rad Company Details
 Table 72. Bio-Rad Business Overview
 Table 73. Bio-Rad Real-time PCR Instruments and Reagents Product
 Table 74. Bio-Rad Revenue in Real-time PCR Instruments and Reagents Business (US$ Million), 2021–2026
 Table 75. Bio-Rad Recent Development
 Table 76. Biosynex Company Details
 Table 77. Biosynex Business Overview
 Table 78. Biosynex Real-time PCR Instruments and Reagents Product
 Table 79. Biosynex Revenue in Real-time PCR Instruments and Reagents Business (US$ Million), 2021–2026
 Table 80. Biosynex Recent Development
 Table 81. Cepheid Company Details
 Table 82. Cepheid Business Overview
 Table 83. Cepheid Real-time PCR Instruments and Reagents Product
 Table 84. Cepheid Revenue in Real-time PCR Instruments and Reagents Business (US$ Million), 2021–2026
 Table 85. Cepheid Recent Development
 Table 86. Hangzhou Bloer Technology Company Details
 Table 87. Hangzhou Bloer Technology Business Overview
 Table 88. Hangzhou Bloer Technology Real-time PCR Instruments and Reagents Product
 Table 89. Hangzhou Bloer Technology Revenue in Real-time PCR Instruments and Reagents Business (US$ Million), 2021–2026
 Table 90. Hangzhou Bloer Technology Recent Development
 Table 91. Liferiver Bio-Tech Company Details
 Table 92. Liferiver Bio-Tech Business Overview
 Table 93. Liferiver Bio-Tech Real-time PCR Instruments and Reagents Product
 Table 94. Liferiver Bio-Tech Revenue in Real-time PCR Instruments and Reagents Business (US$ Million), 2021–2026
 Table 95. Liferiver Bio-Tech Recent Development
 Table 96. Xi'an Tianlong Science and Technology Company Details
 Table 97. Xi'an Tianlong Science and Technology Business Overview
 Table 98. Xi'an Tianlong Science and Technology Real-time PCR Instruments and Reagents Product
 Table 99. Xi'an Tianlong Science and Technology Revenue in Real-time PCR Instruments and Reagents Business (US$ Million), 2021–2026
 Table 100. Xi'an Tianlong Science and Technology Recent Development
 Table 101. Bioperfectus Technologies Company Details
 Table 102. Bioperfectus Technologies Business Overview
 Table 103. Bioperfectus Technologies Real-time PCR Instruments and Reagents Product
 Table 104. Bioperfectus Technologies Revenue in Real-time PCR Instruments and Reagents Business (US$ Million), 2021–2026
 Table 105. Bioperfectus Technologies Recent Development
 Table 106. BGI Group Company Details
 Table 107. BGI Group Business Overview
 Table 108. BGI Group Real-time PCR Instruments and Reagents Product
 Table 109. BGI Group Revenue in Real-time PCR Instruments and Reagents Business (US$ Million), 2021–2026
 Table 110. BGI Group Recent Development
 Table 111. Agilent Technologies Company Details
 Table 112. Agilent Technologies Business Overview
 Table 113. Agilent Technologies Real-time PCR Instruments and Reagents Product
 Table 114. Agilent Technologies Revenue in Real-time PCR Instruments and Reagents Business (US$ Million), 2021–2026
 Table 115. Agilent Technologies Recent Development
 Table 116. Hybribio Company Details
 Table 117. Hybribio Business Overview
 Table 118. Hybribio Real-time PCR Instruments and Reagents Product
 Table 119. Hybribio Revenue in Real-time PCR Instruments and Reagents Business (US$ Million), 2021–2026
 Table 120. Hybribio Recent Development
 Table 121. Shanghai Biogerm Medical Company Details
 Table 122. Shanghai Biogerm Medical Business Overview
 Table 123. Shanghai Biogerm Medical Real-time PCR Instruments and Reagents Product
 Table 124. Shanghai Biogerm Medical Revenue in Real-time PCR Instruments and Reagents Business (US$ Million), 2021–2026
 Table 125. Shanghai Biogerm Medical Recent Development
 Table 126. Shanghai Hongshi Medical Technology Company Details
 Table 127. Shanghai Hongshi Medical Technology Business Overview
 Table 128. Shanghai Hongshi Medical Technology Real-time PCR Instruments and Reagents Product
 Table 129. Shanghai Hongshi Medical Technology Revenue in Real-time PCR Instruments and Reagents Business (US$ Million), 2021–2026
 Table 130. Shanghai Hongshi Medical Technology Recent Development
 Table 131. Suzhou Molarray Company Details
 Table 132. Suzhou Molarray Business Overview
 Table 133. Suzhou Molarray Real-time PCR Instruments and Reagents Product
 Table 134. Suzhou Molarray Revenue in Real-time PCR Instruments and Reagents Business (US$ Million), 2021–2026
 Table 135. Suzhou Molarray Recent Development
 Table 136. Merck Company Details
 Table 137. Merck Business Overview
 Table 138. Merck Real-time PCR Instruments and Reagents Product
 Table 139. Merck Revenue in Real-time PCR Instruments and Reagents Business (US$ Million), 2021–2026
 Table 140. Merck Recent Development
 Table 141. Analytik Jena Company Details
 Table 142. Analytik Jena Business Overview
 Table 143. Analytik Jena Real-time PCR Instruments and Reagents Product
 Table 144. Analytik Jena Revenue in Real-time PCR Instruments and Reagents Business (US$ Million), 2021–2026
 Table 145. Analytik Jena Recent Development
 Table 146. Takara Company Details
 Table 147. Takara Business Overview
 Table 148. Takara Real-time PCR Instruments and Reagents Product
 Table 149. Takara Revenue in Real-time PCR Instruments and Reagents Business (US$ Million), 2021–2026
 Table 150. Takara Recent Development
 Table 151. Meridian Life Science Company Details
 Table 152. Meridian Life Science Business Overview
 Table 153. Meridian Life Science Real-time PCR Instruments and Reagents Product
 Table 154. Meridian Life Science Revenue in Real-time PCR Instruments and Reagents Business (US$ Million), 2021–2026
 Table 155. Meridian Life Science Recent Development
 Table 156. Promega Corporation Company Details
 Table 157. Promega Corporation Business Overview
 Table 158. Promega Corporation Real-time PCR Instruments and Reagents Product
 Table 159. Promega Corporation Revenue in Real-time PCR Instruments and Reagents Business (US$ Million), 2021–2026
 Table 160. Promega Corporation Recent Development
 Table 161. Research Programs/Design for This Report
 Table 162. Key Data Information from Secondary Sources
 Table 163. Key Data Information from Primary Sources
 Table 164. Authors List of This Report


List of Figures
 Figure 1. Real-time PCR Instruments and Reagents Picture
 Figure 2. Global Real-time PCR Instruments and Reagents Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Real-time PCR Instruments and Reagents Market Share by Type: 2025 vs 2032
 Figure 4. Reagent Features
 Figure 5. Instrument Features
 Figure 6. Global Real-time PCR Instruments and Reagents Market Size by Application (US$ Million), 2021–2032
 Figure 7. Global Real-time PCR Instruments and Reagents Market Share by Application: 2025 vs 2032
 Figure 8. Infectious Disease Case Studies
 Figure 9. Prenatal and Postnatal Care Case Studies
 Figure 10. Cancer Screening and Treatment Case Studies
 Figure 11. Organ Transplant Case Studies
 Figure 12. Individual Identification Case Studies
 Figure 13. Agriculture Case Studies
 Figure 14. Customs Quarantine Case Studies
 Figure 15. Food Safety Case Studies
 Figure 16. Forensic Case Studies
 Figure 17. Real-time PCR Instruments and Reagents Report Years Considered
 Figure 18. Global Real-time PCR Instruments and Reagents Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 19. Global Real-time PCR Instruments and Reagents Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 20. Global Real-time PCR Instruments and Reagents Market Share by Region: 2025 vs 2032
 Figure 21. Global Real-time PCR Instruments and Reagents Market Share by Players in 2025
 Figure 22. Global Real-time PCR Instruments and Reagents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 23. The Top 10 and 5 Players Market Share by Real-time PCR Instruments and Reagents Revenue in 2025
 Figure 24. North America Real-time PCR Instruments and Reagents Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. North America Real-time PCR Instruments and Reagents Market Share by Country (2021–2032)
 Figure 26. United States Real-time PCR Instruments and Reagents Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Canada Real-time PCR Instruments and Reagents Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Europe Real-time PCR Instruments and Reagents Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Europe Real-time PCR Instruments and Reagents Market Share by Country (2021–2032)
 Figure 30. Germany Real-time PCR Instruments and Reagents Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. France Real-time PCR Instruments and Reagents Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. U.K. Real-time PCR Instruments and Reagents Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Italy Real-time PCR Instruments and Reagents Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Russia Real-time PCR Instruments and Reagents Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Ireland Real-time PCR Instruments and Reagents Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Asia-Pacific Real-time PCR Instruments and Reagents Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Asia-Pacific Real-time PCR Instruments and Reagents Market Share by Region (2021–2032)
 Figure 38. China Real-time PCR Instruments and Reagents Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Japan Real-time PCR Instruments and Reagents Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. South Korea Real-time PCR Instruments and Reagents Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Southeast Asia Real-time PCR Instruments and Reagents Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. India Real-time PCR Instruments and Reagents Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Australia & New Zealand Real-time PCR Instruments and Reagents Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Latin America Real-time PCR Instruments and Reagents Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Latin America Real-time PCR Instruments and Reagents Market Share by Country (2021–2032)
 Figure 46. Mexico Real-time PCR Instruments and Reagents Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Brazil Real-time PCR Instruments and Reagents Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Middle East & Africa Real-time PCR Instruments and Reagents Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. Middle East & Africa Real-time PCR Instruments and Reagents Market Share by Country (2021–2032)
 Figure 50. Israel Real-time PCR Instruments and Reagents Market Size YoY Growth (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Real-time PCR Instruments and Reagents Market Size YoY Growth (US$ Million), 2021–2032
 Figure 52. UAE Real-time PCR Instruments and Reagents Market Size YoY Growth (US$ Million), 2021–2032
 Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Real-time PCR Instruments and Reagents Business (2021–2026)
 Figure 54. Roche Revenue Growth Rate in Real-time PCR Instruments and Reagents Business (2021–2026)
 Figure 55. DaAn Gene Revenue Growth Rate in Real-time PCR Instruments and Reagents Business (2021–2026)
 Figure 56. Sansure Biotech Revenue Growth Rate in Real-time PCR Instruments and Reagents Business (2021–2026)
 Figure 57. QIAGEN Revenue Growth Rate in Real-time PCR Instruments and Reagents Business (2021–2026)
 Figure 58. Bio-Rad Revenue Growth Rate in Real-time PCR Instruments and Reagents Business (2021–2026)
 Figure 59. Biosynex Revenue Growth Rate in Real-time PCR Instruments and Reagents Business (2021–2026)
 Figure 60. Cepheid Revenue Growth Rate in Real-time PCR Instruments and Reagents Business (2021–2026)
 Figure 61. Hangzhou Bloer Technology Revenue Growth Rate in Real-time PCR Instruments and Reagents Business (2021–2026)
 Figure 62. Liferiver Bio-Tech Revenue Growth Rate in Real-time PCR Instruments and Reagents Business (2021–2026)
 Figure 63. Xi'an Tianlong Science and Technology Revenue Growth Rate in Real-time PCR Instruments and Reagents Business (2021–2026)
 Figure 64. Bioperfectus Technologies Revenue Growth Rate in Real-time PCR Instruments and Reagents Business (2021–2026)
 Figure 65. BGI Group Revenue Growth Rate in Real-time PCR Instruments and Reagents Business (2021–2026)
 Figure 66. Agilent Technologies Revenue Growth Rate in Real-time PCR Instruments and Reagents Business (2021–2026)
 Figure 67. Hybribio Revenue Growth Rate in Real-time PCR Instruments and Reagents Business (2021–2026)
 Figure 68. Shanghai Biogerm Medical Revenue Growth Rate in Real-time PCR Instruments and Reagents Business (2021–2026)
 Figure 69. Shanghai Hongshi Medical Technology Revenue Growth Rate in Real-time PCR Instruments and Reagents Business (2021–2026)
 Figure 70. Suzhou Molarray Revenue Growth Rate in Real-time PCR Instruments and Reagents Business (2021–2026)
 Figure 71. Merck Revenue Growth Rate in Real-time PCR Instruments and Reagents Business (2021–2026)
 Figure 72. Analytik Jena Revenue Growth Rate in Real-time PCR Instruments and Reagents Business (2021–2026)
 Figure 73. Takara Revenue Growth Rate in Real-time PCR Instruments and Reagents Business (2021–2026)
 Figure 74. Meridian Life Science Revenue Growth Rate in Real-time PCR Instruments and Reagents Business (2021–2026)
 Figure 75. Promega Corporation Revenue Growth Rate in Real-time PCR Instruments and Reagents Business (2021–2026)
 Figure 76. Bottom-up and Top-down Approaches for This Report
 Figure 77. Data Triangulation
 Figure 78. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture